title: Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation.
authors.forename: Ryan
authors.initials: R
authors.lastname: Carr
authors.forename: Spero R
authors.initials: SR
authors.lastname: Cataland
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002585:Cesarean Section; D003131:Combined Modality Therapy; D017242:Complement Factor H / Q000172:deficiency / Q000235:genetics; D051056:Complement Inactivating Agents / Q000627:therapeutic use*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D000081208:Hereditary Complement Deficiency Diseases; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000235:genetics*; D007683:Kidney Tubular Necrosis, Acute / Q000209:etiology / Q000628:therapy; D010951:Plasma Exchange; D011183:Postoperative Complications / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011644:Puerperal Disorders / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D012008:Recurrence; D012074:Remission Induction; D006435:Renal Dialysis; D055815:Young Adult; D015432:Glomerulonephritis, Membranoproliferative
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D051056:Complement Inactivating Agents; D017242:Complement Factor H; C481642:eculizumab; D011241:Prednisone